
How Long Do Peptide Studies Run? Endpoint Timelines by Compound Class
Published peptide studies measure endpoints on very different timescales — from hours (Selank, PT-141) to weeks (BPC-157 animal models) to more than a year (GLP-1 class trials). A class-by-class overview of the literature.

How long do peptide studies run before results appear? The answer depends on the compound class, the receptor mechanism, and the endpoint that the study measures. Published studies measure some endpoints within hours and others only after many months.
This article groups research peptides into four classes by the timescale of the endpoints in the published literature. It describes study timelines. It does not describe human use or how to judge effects in a person.
Four timeline classes
| Class | Typical endpoint timing in studies | Mechanism | Examples |
|---|---|---|---|
| 1 — Acute | Minutes to hours | Direct receptor binding | Selank, Semax, PT-141 |
| 2 — Repair-cycle | 1–4 weeks in animal models | Tissue-repair cascade | BPC-157, TB-500, GHK-Cu |
| 3 — Hormonal-axis | 4–26 weeks | Adaptation of a hormone axis | CJC-1295, Ipamorelin, Tesamorelin |
| 4 — Slow-cumulative | 12 weeks to more than a year | Gene expression, mitochondrial and metabolic remodeling | Epithalon, MOTS-c, NAD+, GLP-1 class agonists |
When you compare studies, compare endpoints from the same class. A short study of a Class 4 compound and a short study of a Class 1 compound measure different biology.
Class 1 — acute endpoints (minutes to hours)
These peptides act through direct receptor binding, so studies can measure a response soon after a single administration.
Selank — studied for acute anxiolytic-like effects in rodent behavior models and in small clinical studies in Russia. The proposed mechanism involves modulation of GABAergic signaling and BDNF expression.
Semax — studied for acute effects on attention and for BDNF and NGF expression in rodent brain tissue. Some studies also measure endpoints after repeated administration over 2–4 weeks.
PT-141 (Bremelanotide) — a melanocortin-receptor agonist. Clinical trials measured single-administration endpoints within hours.
Class 2 — repair-cycle endpoints (1–4 weeks)
Tissue-repair studies measure a multi-stage process: angiogenesis, cell migration, and matrix remodeling. Each stage has its own time course. See the tissue repair research guide.
BPC-157 — rodent tendon, ligament, and muscle models typically report angiogenesis markers within the first week and biomechanical and histological endpoints at 1–4 weeks.
TB-500 / Thymosin Beta-4 — studied for actin-dependent cell migration; wound and muscle-injury models report endpoints over 1–3 weeks.
GHK-Cu — wound-model and dermal studies report collagen and gene-expression endpoints over 2–4 weeks.
Class 3 — hormonal-axis endpoints (4–26 weeks)
These compounds change the output of a hormone axis, and downstream tissues adapt slowly. See the GH secretagogue research guide.
CJC-1295 and Ipamorelin — studies of each compound measure IGF-1 changes within weeks. Body-composition endpoints need longer study periods.
Tesamorelin — the registration trials measured visceral adipose tissue at 26 weeks.
Class 4 — slow-cumulative endpoints (12 weeks and longer)
These mechanisms (gene expression, mitochondrial signaling, metabolic remodeling) produce endpoints that need long observation periods. See the cellular longevity research guide.
Epithalon — telomerase and telomere-length endpoints come mainly from cell-culture work and long-term animal studies.
MOTS-c — mouse studies report metabolic endpoints such as insulin sensitivity and exercise capacity over several weeks.
NAD+ — NAD+ levels can change quickly, but tissue-aging biomarkers in studies are measured over months.
Retatrutide — the phase 2 trial reported its primary body-weight endpoint at 48 weeks. The STEP (semaglutide) and SURMOUNT (tirzepatide) programs ran trials of 68–72 weeks.
How to read study timelines
- Compare like with like. Compare endpoints within the same class and the same model.
- Check the endpoint type. Molecular markers usually change before structural or functional endpoints.
- Check the model. Timelines from rodent models do not transfer directly to other species.
- Check the study length. A short study can miss an effect that needs a long observation period.
Further reading
All compounds discussed are chemical reagents for laboratory research only. Not for human or veterinary use. Timelines are summarized from published mechanism and trial literature and are not medical advice.











